Prof Loveday’s perspective on recognising the early signs of Alzheimer’s disease and how an early diagnosis, memory strategies and planning ahead helped her mother live well with Alzheimer’s.
Explore evolving Alzheimer's diagnostic options. Learn how blood biomarker technology innovations like pTau217 are replacing uncertainty with timely clarity for patients and clinicians.
Discover how Roche pRED scientists combine curiosity, data, and AI to addressealthcare’s biggest challenges in ophthalmology, neuroscience, immunology, and oncology.
Roche researchers are working on diagnostic innovations to improve the Alzheimer’s patient journey. One of the most promising areas is the development of simple, accurate blood technologies that can detect key biomarkers associated with the disease.
Silvia didn’t just become her father’s caregiver—she became the balance-keeper at home, supporting both parents as Alzheimer’s reshaped the family’s care ecosystem.
Many people face a long wait for an Alzheimer’s diagnosis—yet early detection can make a meaningful difference. Learn how diagnostic testing can support timely care and planning.
A new guidebook explains how rethinking Alzheimer's clinical trials design and delivery can improve the experiences of participants and their study partners.
Helen is living with Alzheimer’s Disease, and she tells us about her passion for community advocacy and how she has continued this work since her diagnosis.
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
![[Potrait] Helen](https://assets.roche.com/f/176343/2560x1440/8c0e8c2562/helen-2560x1440.png/m/320x240/filters:format(webp):quality(90)/)